Axonia Medical Obtains $2,000,000 Seed Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8dbd84c7-2d04-4c05-84a5-30e2b619c35b&Preview=1 -
Date
5/11/2012 -
Company Name
Axonia Medical -
Mailing Address
4321 Roxbury Lane Kalamazoo, MI 49008 -
Company Description
The concept of Axonia’s technology, which is spun out of the University of Pennsylvania, hinges on the production of axons, the long thin parts of nerve cells that carry signals to distant target cells. Unlike other regenerative treatments in development, Axonia’s method doesn’t involve stem cells. -
Website
http://www.axoniamedical.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,000,000 -
Transaction Round
Seed -
Proceeds Purposes
Axonia Medical will use the seed funding to accelerate development of its lead product for peripheral nerve injury following traumatic injury and tumor resection, areas of significant unmet medical need due to the ineffectiveness and limited utility of current standards of care. -
M&A Terms
-
Venture Investor
Southwestern Michigan First Life Science Venture Fund -
Venture Investor
Ann Arbor SPARK -
Venture Investor
Western Michigan University Research Foundation -
Venture Investor
Biosciences Research and Commercialization Center
